Curt Hanson

Curt Hanson is a prominent figure in clinical laboratory leadership and currently serves as the Executive Vice-President of Mayo Clinic Laboratories at Mayo Clinic Laboratories.2 He is a highly experienced medical professional with a distinguished career spanning several decades.

Professional Background

Hanson completed his residency and fellowship training in Laboratory Medicine and Pathology (LMP) at the University of Minnesota.1 Following his training, he joined the Mayo Clinic's Department of Laboratory Medicine and Pathology, where he has been a practicing hematopathologist since 1993.3

Leadership Roles

Throughout his career, Hanson has held several leadership positions:

• Chief Medical Officer (CMO) at Mayo Clinic Laboratories (until recently)1
• Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic1
• Board Chair of the American Clinical Laboratories Association from 2018 to 20201
• Current board member of Clinical Lab 2.0, a Project Santa Fe Foundation initiative1

Expertise and Contributions

Hanson is recognized as a national leader in clinical laboratory testing, with expertise in various areas:

• Test ordering systems innovation
• Regulatory issues surrounding laboratory developed tests (LDTs)
• Adoption of digital technology and machine learning in laboratory medicine1

He has been instrumental in developing and implementing innovative laboratory solutions, such as overseeing the development of CareSelect™ Lab, a clinical decision support tool designed to improve test order appropriateness and manage utilization.1

Advocacy and Thought Leadership

Hanson has been at the forefront of discussions regarding laboratory test regulations, particularly concerning Laboratory Developed Tests (LDTs). He has testified before the FDA and given talks at professional society meetings, advocating for balanced regulatory approaches that ensure patient safety without impeding innovation and effective patient care.1

With his extensive experience and leadership roles, Curt Hanson has significantly contributed to shaping the field of clinical laboratory medicine and continues to be an influential figure in the industry.